D-DOPA
From Wikipedia, the free encyclopedia
 |
|
| Names | |
|---|---|
| IUPAC name
(R)-2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid
|
|
| Identifiers | |
| 5796-17-8 | |
| ChemSpider | 83260 |
| Jmol interactive 3D | Image |
| PubChem | 92222 |
|
|
|
|
| Properties | |
| C9H11NO4 | |
| Molar mass | 197.19 g/mol |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
| Infobox references | |
D-DOPA (D-3,4-dihydroxyphenylalanine; dextrodopa) is similar to L-DOPA (levodopa), but with opposite chirality. Levo- and dextro- rotation reference a molecule's ability to rotate planes of polarized light in either direction. Whereas L-DOPA is moderately effective in the treatment of Parkinson's disease (PD) and Dopamine-responsive dystonia (DRD) by stimulating the production of dopamine in the brain, D-DOPA is biologically inactive.
See also[edit]
- L-DOPA (Levodopa; Sinemet, Parcopa, Atamet, Stalevo, Madopar, Prolopa, etc.)
- L-DOPS (Droxidopa)
- Methyldopa (Aldomet, Apo-Methyldopa, Dopamet, Novomedopa, etc.)
- Dopamine (Intropan, Inovan, Revivan, Rivimine, Dopastat, Dynatra, etc.)
- Norepinephrine (Noradrenaline; Levophed, etc.)
- Epinephrine (Adrenaline; Adrenalin, EpiPen, Twinject, etc.)
References[edit]
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
